The SOT-Sponsored and SOT-Hosted Meetings described below may be of interest to you. For additional information, please contact the organizers of these meetings directly.
SOT FDA Colloquium on Safety Assessment Approaches in Young Children, May 20
The Society of Toxicology (SOT) US Food and Drug Administration (FDA) Colloquium on Safety Assessment Approaches in Young Children will be held on Friday, May 20, at the US FDA, College Park, Maryland, and also can be accessed as a live webcast. For over a decade, scientists have recognized that children and infants are not simply little adults (WHO Training Report, 2008) and many initiatives and research during life stage have supported this concept. This colloquium will focus on early childhood (from birth to 5 years of age) to examine what those general differences are, provide examples of the differences in this age group, and discuss safety assessment approaches that are being used and proposed. Case studies will be provided and a panel discussion will enhance interaction with the attendees. For additional information and to register, please visit the conference website.
This is the eighth colloquium of a series presented by the SOT in conjunction with the US FDA Center for Food Safety and Applied Nutrition. The series presents scientific information that is high-quality, cutting-edge, future-oriented toxicological science to provide a well-grounded foundation to inform the work of US FDA employees and is open to the public.
SBTOX Offers Nine Toxicology Courses in 2016
The Brazilian Society of Toxicology (SBTOX) is offering a program of nine courses in 2016 to expand toxicological knowledge to help scientists address challenges ranging from occupational health hazards and environmental pollution to drug abuse and deforestration of the Amazon regions. The courses are offered from May 2016 to November 2016. Topics range from "Toxicology and its clinical and forensic implications" to "Cell culture (monolayer and three-dimensional) applied to the study of efficacy and safety of pharmaceutical ingredients and cosmetics." For more information, please visit the SBTOX website.
SOT CCT on Ocular Toxicology, Pharmacology and Drug Delivery: An Eye on the Future, June 27–28
This Society of Toxicology Contemporary Concepts in Toxicology (SOT CCT) conference, Ocular Toxicology, Pharmacology, and Drug Delivery: An Eye on the Future, will provide a forum for communication and interactions between toxicologists, pathologists, clinicians, pharmacologists, basic scientists, and other professionals working in the field of ocular toxicology. This SOT CCT will be held June 27–28, 2016, in South San Francisco, California. The main focus will be two-fold: to improve our understanding of ocular toxicology, pharmacology, and safety assessment and to increase our understanding of the challenges associated with the development of the next generation of ocular drugs and devices. For more information and to register, please visit the conference website.
ASTRA Holds 9th Annual Scientific Meeting, September 21–23
The Australasian College of Toxicology and Risk Assessment (ASTA) is holding its 9th Annual Meeting at Ayers House, Adelaide, South Australia from September 21–23, 2016. The meeting aims to advance the study and applications of toxicology and health risk assessment as professional scientific disciplines by offering the latest research, innovations, case studies, and applications in toxicology and risk assessment. The keynote speaker is William Farland, PhD, Professor, Environmental and Radiological Health Sciences, Colorado State University, Fort Collins. Dr. Farland was the US Environmental Protection Agency Deputy Administrator, Science, from 2001–2006. For more information including continuing education and abstract submission, please visit the conference website.
SOT CCT on Use of Cardiomyocytes for the Assessment of Proarrhythmic Risk, October 25–26
The Use of Cardiomyocytes for the Assessment of Proarrhythmic Risk SOT CCT will be held October 25–26, 2016, in Arlington, Virginia. Human stem cell-derived cardiomyocyte (hiPSC-CMs) are increasingly used in drug discovery, toxicity assessment, and cell-based disease treatment. In vitro screening assays also are used to make decisions about which drug candidates to progress into development. In light of the potential utility of this emergent technology, this workshop will engage experts in presenting and discussing various aspects of the phenotype of these cells (functional, proteins, biochemical) and comparing them to adult ventricular CMs, as a basis for assessing their potential uses in drug and chemical safety testing. This workshop will include domestic and international scientists from government agencies, pharmaceutical industry, and academia to discuss the current state of the art and the path forward. For more information and to register, please visit the conference website.
SOT CCT on Toxicoepigenetics: The Interface of Epigenetics and Risk Assessment, November 2–4
The SOT CCT Toxicoepigenetics: The Interface of Epigenetics and Risk Assessment, will be held November 2–4, 2016, in Tysons, Virginia. The epigenome is a dynamic regulatory framework that controls the use of genomic information to govern the response of cells, tissues, organs, and individuals to their environment. As a master regulator of gene expression, the epigenome is responsive to a diverse range of environmental factors including toxicant exposure, diet, stress, and socioeconomic circumstances. Traditional toxicological paradigms have relied on factors such as age, genetic polymorphisms, and disease status to identify variability in responsiveness to environmental toxicant exposure; however, these factors are neither sufficient to faithfully identify differentially responsive individuals, nor are they modifiable factors that can be leveraged to mitigate adverse health effects of toxicant exposures. An individual’s epigenome, on the other hand, is malleable and shaped by interactions with chemical and non-chemical aspects of the environment, giving it potential as a tool for the promotion of public health. This conference will examine the “state of the science” to identify potential applications and predictable limitations facing the integration of epigenetic data into human health risk assessment paradigms. For more information, please visit the conference website.